E35

N/A

Report date: 2024/09/20 14:48:09
NME

Base Information

Drug NameE35
Drug Alias NameE35E-35
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionS-phase kinase-associated protein 2 inhibitors
TargetsS-phase kinase-associated protein 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhengzhou University
China Registration ClassN/A

Develop Information

Active CompaniesZhengzhou University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A